13 Analysts Have This To Say About Johnson & Johnson
Peering Into Johnson & Johnson's Recent Short Interest
4 Energy Companies Project Tariff Impact, Analyst Raises Price Targets After Q1 Results
Johnson & Johnson Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $169 to $153.
Johnson & Johnson Analyst Ratings
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Evergy Analyst Ratings
U.S. stock market close: The Nasdaq surged over 4%, Chinese concept stocks performed even stronger, and the Golden Dragon Index outperformed the Large Cap.
① High-level economic and trade talks between China and the U.S. exceeded expectations, boosting U.S. stocks; ② Both the S&P and Nasdaq hit new closing highs since March 3; ③ NVIDIA rose over 5%, with its Market Cap returning to above 3 trillion; ④ Trump: Will investigate pharmaceutical companies if necessary.
SA Analyst Upgrades: META, GS, DUK, MSTR, FSLY, TRIN
Roche Plans $700M North Carolina Facility
Innovation, Pharma Profits Won't Suffer Under Trump Prescription Drug EO - White House
Trump's Drug Price Cuts: Will They Work?
WEC Energy Group Appointed Michael Hooper Executive Vice President And Chief Operating Officer
'Trump To Sign Order To Cut Some U.S. Drug Prices To Match Those Abroad' - CNBC
Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company...Ask Your PBM For A List Of Claims'
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Bear Market Is Over, New Bull Will Be a Grind, Not a Moonshot: Evercore ISI
Weekly Earnings Scoreboard: Eight Out of 10 Utility Companies Deliver EPS Wins
Trump Says 'GREAT PROGRESS MADE' at U.S.-China Trade Talks, Which Will Resume Sunday
U.S. Pharma Imports Soar in March as Drugmakers Look to Get Ahead of Potential Tariffs